ANALYSIS OF COAGULATION AND FIBRINOLYSIS DURING INTRAVENOUS-INFUSION OF RECOMBINANT HUMAN TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION

被引:170
作者
COLLEN, D
BOUNAMEAUX, H
DECOCK, F
LIJNEN, HR
VERSTRAETE, M
机构
关键词
D O I
10.1161/01.CIR.73.3.511
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:511 / 517
页数:7
相关论文
共 27 条
[1]   THE FIBRIN PLATE METHOD FOR ESTIMATING FIBRINOLYTIC ACTIVITY [J].
ASTRUP, T ;
MULLERTZ, S .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1952, 40 (02) :346-351
[2]  
BERGMANN SR, 1983, SCIENCE, V220, P1181
[3]  
CLAUSS A., 1957, ACTA HAEMATOL, V17, P237
[4]   CORONARY THROMBOLYSIS WITH RECOMBINANT HUMAN TISSUE-TYPE PLASMINOGEN-ACTIVATOR - A PROSPECTIVE, RANDOMIZED, PLACEBO-CONTROLLED TRIAL [J].
COLLEN, D ;
TOPOL, EJ ;
TIEFENBRUNN, AJ ;
GOLD, HK ;
WEISFELDT, ML ;
SOBEL, BE ;
LEINBACH, RC ;
BRINKER, JA ;
LUDBROOK, PA ;
YASUDA, I ;
BULKLEY, BH ;
ROBISON, AK ;
HUTTER, AM ;
BELL, WR ;
SPADARO, JJ ;
KHAW, BA ;
GROSSBARD, EB .
CIRCULATION, 1984, 70 (06) :1012-1017
[5]   INHIBITION OF PLASMIN BY NORMAL AND ANTIPLASMIN-DEPLETED HUMAN-PLASMA [J].
EDY, J ;
DECOCK, F ;
COLLEN, D .
THROMBOSIS RESEARCH, 1976, 8 (04) :513-518
[6]   CORONARY THROMBOLYSIS AND INFARCT SIZE-REDUCTION AFTER INTRAVENOUS-INFUSION OF RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN NONHUMAN-PRIMATES [J].
FLAMENG, W ;
VANDEWERF, F ;
VANHAECKE, J ;
VERSTRAETE, M ;
COLLEN, D .
JOURNAL OF CLINICAL INVESTIGATION, 1985, 75 (01) :84-90
[7]  
FRIBERGER P, 1979, CHROMOGENIC PEPTIDE, P128
[8]  
GAFFNEY PJ, 1985, THROMB HAEMOSTASIS, V53, P134
[9]  
GOLD HK, 1984, CIRCULATION, V70, P700, DOI 10.1161/01.CIR.70.4.700
[10]   ACUTE CORONARY REOCCLUSION AFTER THROMBOLYSIS WITH RECOMBINANT HUMAN TISSUE-TYPE PLASMINOGEN-ACTIVATOR - PREVENTION BY A MAINTENANCE INFUSION [J].
GOLD, HK ;
LEINBACH, RC ;
GARABEDIAN, HD ;
YASUDA, T ;
JOHNS, JA ;
GROSSBARD, EB ;
PALACIOS, I ;
COLLEN, D .
CIRCULATION, 1986, 73 (02) :347-352